Avadel Pharmaceuticals plc (AVDL)
| Previous Close | 17.30 |
| Open | 17.48 |
| Bid | 17.97 x 100 |
| Ask | 18.06 x 100 |
| Day's Range | 17.26 - 18.16 |
| 52 Week Range | 9.50 - 18.85 |
| Volume | |
| Avg. Volume | 1,234,032 |
| Market Cap | 1.629B |
| Beta (5Y Monthly) | 1.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.00 |
| Earnings Date | Mar 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.90 |
Insider Monkey11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
Simply Wall St.Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future
Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) is possibly approaching a major achievement in its business, so we would...
GlobeNewswireAvadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
DUBLIN, Ireland, April 01, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the 23rd Annual Needham Healthcare Conference on Monday, April 8 at 10:15 a.m. ET. A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90
